← Leaderboards
James Stuart Duncan
Research Inst Of Fox Chase Can Ctr
$3,237,626
Attributed
$3,237,626
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $686.9K · FY2017–25$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,237,626 · 2
By mechanism
R01$3,237,626 · 2
Top collaborators
No co-investigators on record.
Most similar at Research Inst Of Fox Chase Can Ctr
Same institution · by research overlap
- Erica A Golemis$12,682,758
- Yanis Boumber$2,133,668
Others in their field
Other Emerging Leaders on “Mass Spectrum Analysis”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$25,726,378
- Ashlin Bolton · Broad Institute, Inc.$19,699,069
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$14,236,023
- Gregory L Hura · University Of Calif-Lawrenc Berkeley Lab$11,347,896
- Jennifer Cohen Price · University Of California, San Francisco$9,197,178
- Danielle L Swaney · University Of California, San Francisco$8,594,269
Research focus
Mass Spectrum AnalysisTranslatingProtein KinaseMonitorNeoplastic CellSignal TransductionDrug TargetingPhosphotransferasesProteinsProteomicsKinase InhibitorGrowthTumorIn VitroXenograft ProcedureSignal PathwayKnock-DownTechnologyTherapeutic TargetResponseCell LineMalignant NeoplasmsPropertyInnovation
Grant awards (8)
Interrogating MRCK Protein Kinases in Ovarian Cancer$451,910
R01 · FY2025 · CA · contact PI
Interrogating MRCK Protein Kinases in Ovarian Cancer$451,910
R01 · FY2024 · CA · contact PI
Interrogating MRCK Protein Kinases in Ovarian Cancer$235,000
R01 · FY2024 · CA · contact PI
Targeting the kinome in K-ras driven colorectal cancers$427,763
R01 · FY2021 · CA · contact PI
Targeting the kinome in K-ras driven colorectal cancers$427,763
R01 · FY2020 · CA · contact PI
Targeting the kinome in K-ras driven colorectal cancers$406,054
R01 · FY2019 · CA · contact PI
Targeting the kinome in K-ras driven colorectal cancers$418,613
R01 · FY2018 · CA · contact PI
Targeting the kinome in K-ras driven colorectal cancers$418,613
R01 · FY2017 · CA · contact PI